Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.19.3.a.u2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2019
Jun. 30, 2019
Current assets:    
Cash $ 3,637 $ 4,421
Accounts receivable - trade 224 97
Prepaid expenses and other current assets 146 290
Total Current Assets 4,007 4,808
Finance lease right-of-use assets, net of accumulated amortization 28,446 0
Fixed assets, net of accumulated depreciation 2,658 24,380
Intangible assets, net of accumulated amortization 1,249 1,374
Security deposits 24 24
Total Assets 36,384 30,586
Current liabilities:    
Accounts payable (related parties of $0 and $125 as of December 31, 2019 and June 30, 2019, respectively) 442 1,001
Accrued expenses (related party of $702 and $699 as of December 31, 2019 and June 30, 2019, respectively) 1,053 965
Finance lease obligation - current portion 216 0
Capital lease obligation - current portion 0 213
Contract liabilities 3,033 1,279
Total Current Liabilities 4,744 3,458
Finance lease obligation - net of current portion 32,160 0
Capital lease obligation - net of current portion 0 24,671
Total Liabilities 36,904 28,129
Commitments and Contingencies
iBio, Inc. Stockholders' Equity (Deficiency):    
Common stock - $0.001 par value; 275,000,000 shares authorized; 54,567,455 and 20,152,458 shares issued and outstanding as of December 31, 2019 and June 30, 2019, respectively 55 20
Additional paid-in capital 135,071 108,295
Accumulated other comprehensive loss (31) (31)
Accumulated deficit (135,606) (105,821)
Total iBio, Inc. Stockholders' Equity (Deficiency) (511) 2,463
Noncontrolling interest (9) (6)
Total Equity (Deficiency) (520) 2,457
Total Liabilities and Equity (Deficiency) 36,384 30,586
iBio CMO [Member]    
iBio, Inc. Stockholders' Equity (Deficiency):    
Preferred Stock, Value, Issued 0 0
Series A Preferred Stock [Member]    
iBio, Inc. Stockholders' Equity (Deficiency):    
Preferred Stock, Value, Issued 0 0
Series B Preferred Stock [Member]    
iBio, Inc. Stockholders' Equity (Deficiency):    
Preferred Stock, Value, Issued 0 0
Series C Preferred Stock [Member]    
iBio, Inc. Stockholders' Equity (Deficiency):    
Preferred Stock, Value, Issued $ 0 $ 0